Company Overview
About Labviva
Labviva is a Boston-based life sciences technology company founded in 2017 by Lina Nilsson and Barry Bettman. It operates a digital procurement marketplace purpose-built for scientific researchers at pharmaceutical companies, biotech firms, academic research institutions, and hospitals. The platform aggregates product catalogs from thousands of scientific suppliers — including reagents, lab equipment, consumables, and biological materials — into a unified, searchable interface that integrates directly with institutional procurement and ERP systems such as SAP, Coupa, and Jaggaer. This eliminates the fragmented, email-and-catalog-driven purchasing workflows that dominate scientific procurement.
Business Model & Competitive Advantage
The company raised a $22M Series A in 2022 led by Ulu Ventures and MassMutual Ventures. Labviva's marketplace enables procurement teams and researchers to compare products, manage compliance requirements (such as controlled substance tracking and hazardous material handling), track orders across suppliers, and access data-driven insights on purchasing patterns. By integrating with institutional e-procurement systems, Labviva positions itself as an enterprise-grade overlay on top of existing procurement infrastructure rather than a standalone shopping portal — driving faster user adoption in large institutions.
Competitive Landscape 2025–2026
Labviva differentiates in the scientific procurement market — which includes competitors like Quartzy, Biocompare, and direct supplier portals — through its deep ERP integration capability, its compliance-aware purchasing workflows, and its supplier-side analytics tools that give scientific suppliers visibility into buying patterns and competitive positioning. The platform addresses a specialized need: science procurement involves highly technical product specifications, lot traceability requirements, and regulatory constraints that general B2B procurement tools handle poorly.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Florence Healthcare
Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
DNAnexus
DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Compare Labviva with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Labviva? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Labviva Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Labviva vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →